Tevogen TVGN
NASDAQ TVGN
$6.53 -0.17 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) Sale and Maturity of Investments (2023)

Updated

Tevogen (TVGN) reported Sale and Maturity of Investments of $9.71 million for Q4 2023.

Analysis

Tevogen (TVGN) Sale and Maturity of Investments (2023) Analysis & Trends

For FY2023, Tevogen posted Sale and Maturity of Investments of $342.98 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Tevogen 27.79 Mn 27.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 9.71 Mn
Mar 31, 2023 333.27 Mn
API Access

Tevogen Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=TVGN&period=max&api_key=YOUR_API_KEY